Company: ABBV
Filing Date: 2025-03-24
Form Type: DEF 14A
Source: 0001558370-25-003537
Chunk: 24

Company: AbbVie Inc.
Filing Date: 2025-03-24
Form: DEF 14A
Chunk 24
---
 | The table includes shares held in the executive officers’ accounts in the AbbVie Savings Plan as follows: all executive officers as a group, 3,128. Each executive officer has shared voting power and sole investment power with respect to the shares held in his or her account. |

| (2) | The table includes restricted stock units held by the non-employee directors. The directors’ units are payable in stock as described in footnote (2) to the Director Compensation table. |

| (3) | The table includes shared voting and/or investment power over shares as follows: J. Stewart, 1,338; A. Saleki-Gerhardt, 6,474; T. Freyman, 7,882; E. Rapp, 10,388; G. Tilton, 350; and all directors and executive officers as a group, 26,959. |

| (4) | The directors and executive officers as a group own less than one percent of the outstanding shares of AbbVie. |

Securities Ownership of Principal Stockholders The table below reports the number of shares of AbbVie common stock beneficially owned as of December 31, 2024, by each person known to AbbVie to own beneficially more than 5% of AbbVie’s outstanding common stock.

2025 Proxy Statement |31

| ​                    | ​ |
| SECURITIES OWNERSHIP | ​ |

|                                      |  ​ |                           |                   |
| Name and Address of Beneficial Owner |  ​ | Shares Beneficially Owned | Percent of Class* |
| The Vanguard Group                   | -1 |               160,380,057 | 9.06%             |
| 100 Vanguard Blvd.                   |  ​ |                         ​ | ​                 |
| Malvern, PA 19355                    |  ​ |                         ​ | ​                 |
| BlackRock, Inc.                      | -2 |               143,180,060 | 8.09%             |
| 50 Hudson Yards                      |  ​ |                         ​ | ​                 |
| New York, NY 10001                   |  ​ |                         ​ | ​                 |

(1) Based solely on the Schedule 13G/A filed with the SEC on February 13, 2024, reporting beneficial ownership as of December 31, 2023, by The Vanguard Group, which has shared voting power with respect to 2,359,434 shares, sole dis